Review Article
The Risk of Gastrointestinal Hemorrhage in Low-Dose Aspirin Users with Diabetes Mellitus: Systematic Review and Meta-Analysis
Table 1
Characteristics of studies included in the meta-analysis.
| Study | Ages | Gender: male : female | Aspirin dosage (mg/day) | Aspirin duration | Cases: inclusion criteria | NOS score |
| Dai et al. 2014 [15] | | 64 : 40 | 100 | 3 months–15 years | Upper GI hemorrhage | 5 | Guo and Zhang 2017 [16] | | 80 : 56 | 100 | 3 months–14 years | GI hemorrhage | 7 | Kawamura et al. 2013 [17] | NR | NR | 75 | ≥3 months | Ulcer as a mucosal deficit >5 mm in diameter | 8 | Li et al. 2015 [18] | | 118 : 102 | 100 | ≥3 months; mean months: | Gastrorrhagia and/or duodenal hemorrhage | 7 | Luo 2016 [19] | | 120 : 56 | NR | ≥2 months | Upper GI hemorrhage | 5 | Negovan et al. 2016 [20] | NR | NR | 75-325 | ≥1 months | Gastroduodenal ulcer and/or hemorrhage | 6 | Quan 2015 [21] | | 113 : 87 | NR | ≥2 months | Upper GI hemorrhage | 8 | Zhang et al. 2016 [22] | | 210 : 130 | ≤100 | ≥7 days | GI hemorrhage | 5 |
|
|
NR: not report; GI: gastrointestinal.
|